AVITA Medical(RCEL) - 2024 Q1 - Quarterly Results

VALENCIA, Calif., May 13, 2024 — AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a commercial-stage regenerative medicine company focused on first-in-class devices for wound care management and skin restoration, today reported financial results for the first quarter ended March 31, 2024. Financial Results and Recent Business Updates "We believe we have taken the necessary measures to invigorate our burns business and improve our commercial sales process to return to sustained growth," said Jim Corbett, AVITA ...